Baseline | TVC | |||
---|---|---|---|---|
cHRa (95 % CI) | aHRb ((95 % CI) | cHRa ((95 % CI) | aHRb ((95 % CI) | |
Sex (Male) | 1.15 (1.14-1.17 | 1.23 (1.22-1.26) | 1.15 (1.14-1.17) | 1.15 (1.14-1.17) |
Age | 1.05 (1.05-1.06) | 1.04 (1.04-1.04) | 1.06 (1.05-1.06) | 1.03 (1.03-1.03) |
Region of Residence | ||||
Urban | 1.01 (.99-1.03) | 1.10 (1.08-1.12) | 1.01 (.99-1.03) | 1.09 (1.07-1.11) |
Income Quintile | ||||
(Compared to 1- Lowest) | ||||
2 | .88 (.86-.90) | .95 (.93-.98) | .88 (.86-.90) | .97 (.95-.99) |
3 | .81 (.79-.83) | .92 (.90-.94) | .81 (.79-.83) | .94 (.92-96) |
4 | .69 (.67-.71) | .86 (.85-.89) | .69 (.67-.71) | .91 (.88-.95) |
5 – Highest Income Quintile | .65 (.63-.66) | .85 (.82-.87) | .65 (.63-.66) | .93 (.90-.95) |
Charlson Comorbidities | ||||
Myocardial infarction | 2.2 (2.15-2.25) | 1.07 (1.05-1.1) | 2.89 (2.84-2.94) | 1.2 (1.18-1.22) |
Congestive heart failure | 4.19 (4.11-4.27) | 1.77 (1.73-1.81) | 5.21 (5.13-5.29) | 1.88 (1.84-1.92) |
Peripheral vascular disease | 2.99 (2.9-3.07) | 1.24 (1.2-1.28) | 3.31 (3.24-3.38) | 1.16 (1.14-1.19) |
Cerebrovascular disease | 2.87 (2.8-2.93) | 1.28 (1.24-1.31) | 3.65 (3.59-3.72) | 1.41 (1.38-1.43) |
Hemiplegia or paraplegia | 7.64 (7.43-7.85) | 2.36 (2.29-2.43) | 8.82 (8.66-8.98) | 2.89 (2.83-2.95) |
Dementia | 1.88 (1.85-1.91) | 1.31 (1.29-1.34) | 2.16 (2.12-2.19) | 1.3 (1.28-1.32) |
Chronic pulmonary disease | 1.69 (1.61-1.76) | 1.18 (1.13-1.24) | 1.62 (1.56-1.67) | 1.03 (0.99-1.07) |
Rheumatologic disease | 1.67 (1.61-1.73) | 1.1 (1.06-1.14) | 2.02 (1.96-2.07) | 1.1 (1.08-1.13) |
Peptic ulcer disease | 2.31 (2.21-2.42) | 1.69 (1.6-1.78) | 2.66 (2.58-2.74) | 1.56 (1.51-1.62) |
Diabetes without chronic complications | 2.18 (2.13-2.23) | 1.3 (1.27-1.33) | 2.16 (2.12-2.2) | 1.1 (1.07-1.12) |
Diabetes with chronic complications | 3.27 (3.14-3.4) | 1.41 (1.35-1.48) | 3.8 (3.71-3.9) | 1.27 (1.23-1.31) |
Renal disease | 3.45 (3.28-3.62) | 1.44 (1.36-1.52) | 4.18 (4.04-4.33) | 1.36 (1.31-1.41) |
Any malignancy, including leukemia and lymphoma | 3.52 (3.41-3.64) | 1.63 (1.57-1.69) | 4.78 (4.68-4.87) | 1.72 (1.69-1.76) |
Metastatic solid tumor | 3.11 (3.04-3.18) | 1.5 (1.47-1.54) | 4.49 (4.42-4.57) | 1.87 (1.83-1.90) |
Mild liver disease | 5.7 (5.23-6.21) | 1.97 (1.79-2.17) | 7.1 (6.73-7.49) | 2.1 (1.98-2.23) |
Moderate or severe liver disease | 8.34 (8.04-8.65) | 3.58 (3.43-3.73) | 13.26 (12.99-13.53) | 5.15 (5.03-5.28) |
AIDS/HIV | 1.86 (1.42-2.44) | 1.72 (1.28-2.31) | 2 (1.62-2.46) | 1.65 (1.32-2.06) |